Alliance Study Shows New Promise Against Locally Advanced Lung Cancer Immunotherapy combined with chemotherapy before surgery improves outcomes for patients with stage III non-small cell lung cancers
New findings of an Alliance Foundation Trials study show combining immunotherapy and chemotherapy before surgery improves outcomes for some patients with locally advanced non-small cell lung cancer, according to the results of AFT-46/CHIO3 published in Lung Cancer. “These results are exciting because they give us a new, successful blueprint for treating stage III lung cancer…